Response to aflibercept in patients with fibrovascular pigment epithelial detachment refractory to ranibizumab in exudative age-related macular degeneration

被引：1
|
作者：
Tran, T. H. C. [1 ]
Dumas, S. [2 ]
Coscas, F. [3 ,4 ]
机构：
[1] Univ Catholique Lille, Grp Hop Catholique Lille, Serv Ophtalmol, Blvd Belfort,BP 387, F-59020 Lille, France
[2] Clin Louviere, F-59042 Lille, France
[3] Ctr Ophtalmol Odeon, F-75006 Paris, France
[4] Univ Paris Est Creteil, Ctr Hosp Intercommunal Creteil, Creteil, France
来源：
JOURNAL FRANCAIS D OPHTALMOLOGIE | 2017年 / 40卷 / 03期
关键词：
ANTI-VEGF THERAPY; NEOVASCULAR AMD; BEVACIZUMAB;
D O I：
10.1016/j.jfo.2016.11.007
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
引用
收藏
页码：E99 / E101
页数：3
相关论文
共 50 条
  • [1] Intravitreal ranibizumab for treatment of fibrovascular pigment epithelial detachment in age-related macular degeneration
    Yolcu, Umit
    Tas, Ahmet
    Altun, Salih
    CANADIAN JOURNAL OF OPHTHALMOLOGY-JOURNAL CANADIEN D OPHTALMOLOGIE, 2015, 50 (05): : 395 - 395
  • [2] Intravitreal ranibizumab for the treatment of fibrovascular pigment epithelial detachment in age-related macular degeneration
    Iordanous, Yiannis
    Powell, Anne-Marie
    Mao, Alex
    Hooper, Philip L.
    Eng, Kenneth T.
    Schwartz, Carol
    Kertes, Peter J.
    Sheidow, Thomas G.
    CANADIAN JOURNAL OF OPHTHALMOLOGY-JOURNAL CANADIEN D OPHTALMOLOGIE, 2014, 49 (04): : 367 - 376
  • [3] Intravitreal ranibizumab for treatment of fibrovascular pigment epithelial detachment in age-related macular degeneration Reply
    Iordanous, Yiannis
    Sheidow, Tom G.
    CANADIAN JOURNAL OF OPHTHALMOLOGY-JOURNAL CANADIEN D OPHTALMOLOGIE, 2015, 50 (05): : 396 - 396
  • [4] PIGMENT EPITHELIAL DETACHMENT RESPONSE TO AFLIBERCEPT IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION REFRACTORY TO RANIBIZUMAB Time Course and Drug Effects
    De Massougnes, Sophie
    Dirani, Ali
    Ambresin, Aude
    Decugis, Doris
    Marchionno, Laetitia
    Mantel, Irmela
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2016, 36 (05): : 881 - 888
  • [5] Response of retinal pigment epithelial detachments to intravitreal aflibercept in neovascular age-related macular degeneration refractory ranibizumab
    Ogata, N.
    Hasegawa, T.
    Yamashita, M.
    Okamoto, M.
    ACTA OPHTHALMOLOGICA, 2013, 91
  • [6] Efficacy and Safety of Aflibercept in Fibrovascular Retinal Pigment Epithelium Detachment refractory to prior ranibizumab therapy in neovascular Age-related macular degeneration (AMD).
    Thi Ha Chau Tran
    Dumas, Stephane
    Coscas, Florence
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2016, 57 (12)
  • [7] Treatment of refractory pigment epithelial detachment secondary to exudative age-related macular degeneration.
    Gonzalez, Andres
    Khurshid, Gibran S.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2017, 58 (08)
  • [8] Effect of Aflibercept and Bevacizumab for Ranibizumab-Refractory Exudative Age-Related Macular Degeneration
    Kim, Bo Hee
    Seo, Young Seung
    Chung, Hum
    Heo, Jang Won
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2015, 56 (07)
  • [9] Two-Year Outcome of Aflibercept in Patients with Pigment Epithelial Detachment due to Neovascular Age-Related Macular Degeneration (nAMD) Refractory to Ranibizumab
    Thi Ha Chau Tran
    Dumas, Stephane
    Coscas, Florence
    JOURNAL OF OPHTHALMOLOGY, 2017, 2017
  • [10] Intravitreal Aflibercept in Neovascular Age-Related Macular Degeneration and Pigment Epithelial Detachment
    Felix, Armada
    Cidad, Pino
    Pastora, Natalia
    Manzano, Beatriz
    Rosa, Irene
    Del Barrio, Zurine
    Mediero, Soraya
    Capote, Maria
    DAnna, Oriana
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2014, 55 (13)
12345